PHF19
PHD finger protein 19
Also known as: DKFZP727G051, MTF2L1, PCL3, PHF19_HUMAN, TDRD19B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T6S3
- Gene
- PHF19
- Ensembl
- ENSG00000119403
- Chromosome
- 9
- Canonical length
- 580 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables methylated histone binding activity. Involved in negative regulation of gene expression, epigenetic. Located in ESC/E(Z) complex. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
580 residues, UniProt reviewed canonical sequence.
>Q5T6S3|PHF19
1 MENRALDPGT RDSYGATSHL PNKGALAKVK NNFKDLMSKL TEGQYVLCRW TDGLYYLGKI
61 KRVSSSKQSC LVTFEDNSKY WVLWKDIQHA GVPGEEPKCN ICLGKTSGPL NEILICGKCG
121 LGYHQQCHIP IAGSADQPLL TPWFCRRCIF ALAVRKGGAL KKGAIARTLQ AVKMVLSYQP
181 EELEWDSPHR TNQQQCYCYC GGPGEWYLRM LQCYRCRQWF HEACTQCLNE PMMFGDRFYL
241 FFCSVCNQGP EYIERLPLRW VDVVHLALYN LGVQSKKKYF DFEEILAFVN HHWELLQLGK
301 LTSTPVTDRG PHLLNALNSY KSRFLCGKEI KKKKCIFRLR IRVPPNPPGK LLPDKGLLPN
361 ENSASSELRK RGKSKPGLLP HEFQQQKRRV YRRKRSKFLL EDAIPSSDFT SAWSTNHHLA
421 SIFDFTLDEI QSLKSASSGQ TFFSDVDSTD AASTSGSAST SLSYDSRWTV GSRKRKLAAK
481 AYMPLRAKRW AAELDGRCPS DSSAEGASVP ERPDEGIDSH TFESISEDDS SLSHLKSSIT
541 NYFGAAGRLA CGEKYQVLAR RVTPEGKVQY LVEWEGTTPYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PHF19 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 54 nTPM
- tonsil: 43 nTPM
- blood vessel: 39 nTPM
- lymph node: 38 nTPM
- thymus: 36 nTPM
- pituitary gland: 29 nTPM
Single-cell type
- monocyte progenitors: 82 nCPM
- esophageal basal cells: 63 nCPM
- monocytes: 61 nCPM
- megakaryocyte progenitors: 53 nCPM
- hofbauer cells: 46 nCPM
- plasma cells: 42 nCPM
Immune cell
- non-classical monocyte: 80 nTPM
- intermediate monocyte: 58 nTPM
- T-reg: 32 nTPM
- myeloid DC: 14 nTPM
- classical monocyte: 14 nTPM
- memory CD4 T-cell: 12 nTPM
Brain region
- white matter: 49 nTPM
- medulla oblongata: 34 nTPM
- basal ganglia: 34 nTPM
- midbrain: 31 nTPM
- cerebral cortex: 29 nTPM
- thalamus: 29 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.35
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of gene expression, epigenetic
- negative regulation of transcription by RNA polymerase II
- stem cell differentiation
- stem cell population maintenance
Molecular functions
- chromatin binding
- DNA binding
- histone H3K36me3 reader activity
- histone H3K4me3 reader activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, PHD-type
- Tudor domain
- Zinc finger, FYVE/PHD-type
- Zinc finger, RING/FYVE/PHD-type
- Zinc finger, PHD-type, conserved site
- Zinc finger, PHD-finger
- Polycomb-like MTF2 factor 2, C-terminal domain
- Lysine-specific demethylase 4-like, Tudor domain
- PHD-finger
- Polycomb-like MTF2 factor 2
- Jumonji domain-containing protein 2A Tudor domain
- PHF19, PHD domain 2
- PHD finger protein 19, Tudor domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PHF19 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PHF19 as an antibody target. Whether an autoantibody or antibody against PHF19 could matter depends on whether native PHF19 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PHF19 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PHF19 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...